Home / BPA - Consumable Supplies for Terumo Trima Accel Blood… / Document

NMR Waiver - Terumo Blood Products

Updated

A PDF document (192 KB) attached to BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems, from the Defense Health Agency (DHA). Due Dec 2, 2026, 12:00 PM (UTC-5).

File name: NMR Waiver HT9426-27-Q-E003 - Terumo Blood Products.pdf

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview

Office of Industrial Base Resilience and Contracting | www.sba.gov 409 Third St. SW | Washington, DC 20416

Via Email: [email protected]
November 13, 2026
Mr. Jeremy McMurry
Contracting Officer
Defense Health Agency
RE: NMR Individual Waiver Request, HT9426-27-Q-E003, Terumo Trima Accel Blood Collection System
Dear Mr. McMurry:
Your request for an individual Nonmanufacturer Rule (NMR) waiver is approved. On November 3, 2026, the U.S. Small Business Administration (SBA) received an individual NMR waiver request from the Defense Health Agency (DHA). The agency is establishing a Blanket Purchase Agreement (CPA) to procure multiple parts supporting a blood collection system. The applicable North American Industry Classification System (NAICS) code for this procurement is 325413 – In Vitro Diagnostic Substance Manufacturing and the estimated value of this procurement is $300,000.00. (This estimated contract award value includes delivery, shipping and installation fees but these services are not subject to the NMR rule.)
The waiver of the NMR on an individual procurement is provided for in section 8(a)(17) of the Small Business Act, 15 U.S.C. § 637(a)(17), and section 121.406(b)(5) of title 13 of the Code of Federal Regulations, 13 C.F.R. § 121.406(b)(5). At a minimum, an individual NMR waiver request must include the specific item to be waived, why the specific item is required, the proposed solicitation number, the NAICS code, the dollar amount of the procurement, a brief statement of the procurement history, and a Statement of Work (for contracts expected to exceed $500,000). 13 C.F.R. § 121.1204(b)(1). In addition, the contracting officer must provide a determination that no small business manufacturer can reasonably be expected to offer the product(s) required under the solicitation. This determination must be supported by a narrative of market research and supporting documentation. 13 C.F.R. § 121.1204(b)(1)(iii).
All SBA programs and services are extended to the public on a nondiscriminatory basis.

According to DHA’s submission, an individual NMR waiver is sought for parts that support the Terumo Trima Accel Blood Collection System. The items included in the request are: Item Name
Teruflex 500ml collection
bags, 24 per case
Trima Platelet Kit
Isoplate Solution (PAS-F)
TSCD Wafers
ACD-A Solution, 750ml bag
150 mL, one coupler

Stock Number

1BB*AGD506A2

82460
40850
1SC*W017
40817

1BB*T015CB70YY

The Terumo Trima Accel Blood Collection System is FDA-approved, but only with the use of original

The beginning of the document. Download the full file to read on.

Other documents in this bid